Search This Blog

Wednesday, September 30, 2020

Pulmonx raises price range of its upsized IPO of 10M shares

Pulmonx (LUNG) has upsized its IPO from 6.67M to 10M shares and raised the price range to $17-$18 vs. prior range of $14-$16 per share.

Proceeds will be used to hire sales and marketing people, fund R&D, to pay a success fee to Oxford of $1.9M and for working capital.

Pulmonx is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).

Source

https://seekingalpha.com/news/3618300-pulmonx-raises-price-range-of-upsized-ipo-of-10m-shares

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.